News | May 05, 2025
Tatva Chintan Pharma Chem reports consolidated Q4 FY25 PAT at Rs. 1.03 Cr
The company has posted net profit of Rs.5.71 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs.5.71 crores for the Financial Year ended March 31, 2025
Express Scripts has added YESINTEK to the National Preferred Formulary (NPF) effective March 21, 2025
RPG Life Sciences has reported total income of Rs. 148.15 crores during the period ended March 31, 2025
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
Ticagrelor tablets are indicated for to reduce the risk of cardiovascular death and myocardial infarction,
Vimta Labs has reported total income of Rs. 96.08 crores during the period ended March 31, 2025
The company has posted net profit of Rs. 406.7 crores for the Financial Year ended March 31, 2025
The company has reported total income of Rs. 628.4 crores during the period ended March 31, 2025
The closing of the Block Acquisition is now expected to be completed by Q3 2025
For the financial year ended March 31, 2025, Thyrocare has reported total income of Rs.702.18 crores
Subscribe To Our Newsletter & Stay Updated
